|
|
Volumn 66, Issue 2, 2008, Pages 184-186
|
|
Pharmacovigilance: What to do if you see an adverse reaction and the consequences
|
|
Author keywords
Gadolinium contrast agents; Nephrogenic systemic fibrosis; Pharmacovigilance
|
|
Indexed keywords
DECISION MAKING;
DRUG PRODUCTS;
GADOLINIUM;
HEALTH CARE;
NEPHROGENIC SYSTEMIC FIBROSIS;
PHARMACOVIGILANCE;
RADIOLOGY;
GADOBENIC ACID;
GADOBUTROL;
GADODIAMIDE;
GADOFOSVESET;
GADOLINIUM;
GADOLINIUM PENTETATE;
GADOTERIC ACID;
GADOTERIDOL;
GADOVERSETAMIDE;
GADOXETIC ACID;
ARTICLE;
DISEASE REGISTRY;
DISEASE SEVERITY;
DRUG CONTRAINDICATION;
DRUG MARKETING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
HEALTH CARE PERSONNEL;
HUMAN;
KIDNEY FAILURE;
KIDNEY FIBROSIS;
MEDICAL DECISION MAKING;
MEDICAL PRACTICE;
NEPHROGENIC SYSTEMIC FIBROSIS;
PATIENT SAFETY;
PRIORITY JOURNAL;
RISK REDUCTION;
UNSPECIFIED SIDE EFFECT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
CONTRAST MEDIA;
FIBROSIS;
GADOLINIUM;
HUMANS;
KIDNEY DISEASES;
MAGNETIC RESONANCE IMAGING;
PRODUCT SURVEILLANCE, POSTMARKETING;
SKIN DISEASES;
|
|
EID: 43049123056
PISSN: 0720048X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejrad.2008.02.009 Document Type: Article |
|
Times cited : (18)
|
|
References (7)
|
